Objective: Patient registries can effectively collect data over a long period of time to provide a better understanding of the typical presentation of specific conditions. The autism spectrum disorders (ASDs) have experienced a marked increase in reported prevalence over the past 20 years for reasons that are not completely clear. The Autism Treatment Network (ATN) Registry was established to facilitate investigations into a variety of questions critical to expanding our understanding of ASDs. Here we describe the establishment of the registry, its components, some of its findings to date, and opportunities for further use of this data.
Methods: Participants are eligible for enrollment into the ATN registry if they are between the ages of 2.0 and 17.6 years at the time of enrollment and meet criteria for ASD as determined by clinical consensus on the basis of specific diagnostic measures (Autism Diagnostic Observation Schedule/Autism Diagnostic Observation Schedule, Second Edition; Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition/Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition). Baseline measures include demographics, autism assessment, cognitive assessment data, behavioral data, sleep habits, quality of life, sensory data, and treatments. Several of the measures are collected at annual follow-up visits.
Results: More than 6800 children with ASD have been enrolled in the Autism Speaks ATN registry. Data from the registry have been reported at numerous scientific meetings and in several publications and have led to new recommendations for best practices in the management of ASD.
Conclusions: A patient registry for children and adolescents with ASD has had and will continue to have a significant impact on care for this population. Investigators are encouraged to query this database to further its impact by testing novel hypotheses and conducting preliminary proof-of-concept analyses.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1542/peds.2015-2851E | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Acute kidney injury in coronavirus disease: a comparative study of the two waves in Brazil.
Einstein (Sao Paulo)
October 2024
Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brazil.
Article Synopsis
- - Magalhães et al. found a high incidence of acute kidney injury among hospitalized COVID-19 patients, particularly in the second wave, which was more severe despite similar mortality rates due to vaccine effectiveness and improved clinical practices.
- - Risk factors for acute kidney injury included the use of diuretics, mechanical ventilation, and certain laboratory markers like proteinuria and D-dimer levels.
- - In a study of 887 hospitalized patients in São Paulo, acute kidney injury was seen in 48.1%, with 38.9% overall mortality, highlighting the urgency in managing renal issues in COVID-19 cases.
Human Alzheimer's Disease ATN/ABC Staging Applied to Aging Rhesus Macaque Brains: Association With Cognition and MRI-Based Regional Gray Matter Volume.
J Comp Neurol
September 2024
Department of Neuroscience, Banner Sun Health Research Institute, Sun City, Arizona, USA.
The brain changes of Alzheimer's disease (AD) include Abeta (Aβ) amyloid plaques ("A"), abnormally phosphorylated tau tangles ("T"), and neurodegeneration ("N"). These have been used to construct in vivo and postmortem diagnostic and staging classifications for evaluating the spectrum of AD in the "ATN" and "ABC" ("B" for Braak tau stage, "C" for Consortium to Establish a Registry for Alzheimer's Disease [CERAD] neuritic plaque density) systems. Another common AD feature involves cerebral amyloid angiopathy (CAA).
View Article and Find Full Text PDFClinical and pathological characteristics of patients with acute kidney injury in Japan in whom kidney biopsy was performed: a cross-sectional analysis of the Japan Renal Biopsy Registry (J‑RBR).
Clin Exp Nephrol
October 2022
Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
Introduction: Acute kidney injury (AKI) is a worldwide concern and it leads to a poor prognosis or end-stage kidney disease. The purpose of this study was to clarify the characteristics of patients with AKI in whom kidney biopsy was performed using data of the Japan Renal Biopsy Registry (J-RBR).
Methods: We screened 38,351 cases that were registered in the J-RBR from 2007 to 2018.
Theoretical impact of the AT(N) framework on dementia using a community autopsy sample.
Alzheimers Dement
December 2021
Department of Medicine, University of Washington, Seattle, Washington, USA.
The AT(N) research framework categorizes eight biomarker profiles using amyloid (A), tauopathy (T), and neurodegeneration (N), regardless of dementia status. We evaluated associations with dementia risk in a community-based cohort by approximating AT(N) profiles using autopsy-based neuropathology correlates, and considered cost implications for clinical trials for secondary prevention of dementia based on AT(N) profiles. We used Consortium to Establish a Registry for Alzheimer's Disease (moderate/frequent) to approximate A+, Braak stage (IV-VI) for T+, and temporal pole lateral ventricular dilation for (N)+.
View Article and Find Full Text PDFGreek Registry of Cerebral Aneurysms.
J Neurol Surg A Cent Eur Neurosurg
March 2021
Department of Neurosurgery, University General Hospital of Thessaloniki AHEPA, Thessaloniki, Central Macedonia, Greece.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!